Renaissance Technologies LLC Makes New $3.45 Million Investment in Celldex Therapeutics, Inc. (NASDAQ:CLDX)
Renaissance Technologies LLC bought a new stake in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 136,588 shares of the biopharmaceutical company’s stock, valued at approximately $3,452,000. Renaissance Technologies LLC owned about 0.21% […]
Renaissance Technologies LLC bought a new stake in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 136,588 shares of the biopharmaceutical company’s stock, valued at approximately $3,452,000. Renaissance Technologies LLC owned about 0.21% […]
